Aileron Therapeutics, Inc. announced that Armen B. Shanafelt, Ph.D. and Caleb Winder have not been nominated and will not stand for re-election as Class II directors. Upon the expiration of Dr. Shanafelt’s and Mr. Winder’s term at the annual meeting, Dr. Shanafelt and Mr. Winder will cease to serve as directors.